USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Fisher & Paykel Healthcare Limited

USPTO PatentsView assignee record - 1,077 granted patents across 67 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor).

RSS updates for this company

The verdict

According to USPTO PatentsView, Fisher ranks #420 of 49,997 tracked US assignees by granted-patent volume, with 1,077 patents across 67 technology areas.

#420
of 49,997 US assignees by volume
Top 1%
by Innovation Score (66.4/100)
15.6
avg claims per patent
+132%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R420 · Foreign Corporation #420 · 1,077 grants

GRANTS-LARGE · TOP-DECILE · PHOTO-FINISH · CPC-WIDE · INNOV-STRONG · CLAIMS-RICH · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL

  • GRANTS-LARGE 1.1K grants
  • TOP-DECILE #420/49,997
  • PHOTO-FINISH Screen Holdings
  • CPC-WIDE A61M · 67 areas
  • INNOV-STRONG 66.4/100
  • CLAIMS-RICH 15.6 claims/avg
  • TYPE-FRNCORP Foreign Corp
  • VEL-SURGE +132% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: Screen Holdings Co., Ltd. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Innovation-score neighbourhood around Fisher

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Fisher's Innovation Score is 66.4/100 (top 1% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

How Fisher's grant cadence moved

Between 2020–2024, Fisher & Paykel Healthcare Limited received 655 grants versus 282 in 2015–2019 (+132% equal-window velocity, above median growth). Across complete PatentsView years, output peaked in 2024 at 163 grants and bottomed in 2015 at 28. Lead class A61M accounts for 71.8% of the portfolio across 67 subclasses. Volume neighbours: University of South Florida (#416) and Hitachi High-Technologies Corporation (#424).

Fisher's three-year grant acceleration

From 2019–2021 to 2022–2024, Fisher & Paykel Healthcare Limited moved from 348 to 411 grants (1.18x the prior three-year total, a multiple, not a CAGR). Among 3,296 tracked assignees with ≥100 grants and ≥20 prior-period grants, that multiple ranks #814. See the growth leaderboard.

Who files at Fisher's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Fisher holds 1,077 patents at rank #420, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Fisher

By rank, the assignees closest to #420 in granted patent volume.

Leaders in A61M (Devices FOR Introducing Media Into)

Other assignees with the most granted patents in Fisher's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Fisher, neither rank-band nor same-CPC leaders (those blocks stay above).

Fisher's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

66 Top 1% higher than 99% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

050100150200 20152016201720182019202020212022202320242025 140
USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
Fisher & Paykel Healthcare Limited patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 28 2.6%
2016 33 3.1%
2017 38 3.5%
2018 79 7.3%
2019 104 9.7%
2020 125 11.6%
2021 119 11.0%
2022 121 11.2%
2023 127 11.8%
2024 163 15.1%
2025partial year 140 13.0%

Which technologies does Fisher & Paykel Healthcare Limited patent most?

Top 15 of 67 technology areas

Where it ranks

Overall rank by patents

#420

of 49,997 tracked assignees

Innovation Score

66.4 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

Fisher & Paykel Healthcare Limited's patent record in context - here's where to go next.

  • Fisher & Paykel Healthcare Limited's lead technology class is A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor), 71.8% of its portfolio - see every assignee active in that class. Explore A61M
  • Ranked #420 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Fisher & Paykel Healthcare Limited against University of South Florida, an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 66.4/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.